Kanoria Chemicals & Industries Complete Financial Statements

12 Years of Data
2026 - 2015

In FY2026, Kanoria Chemicals & Industries (KANORICHEM) reported revenue ₹312 Cr, net profit ₹32 Cr and EPS ₹7.24, with a net profit margin of 10.3% and ROE of 5.6%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Examine KANORICHEM quarterly trends for recent quarterly revenue, profit and EPS trends.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 10.26% 2026 data
EBITDA Margin 10.90% 2026 data
Operating Margin 9.00% 2026 data
Return on Assets 2.86% 2026 data
Return on Equity 5.58% 2026 data

Balance Sheet Ratios

Current Ratio 1.22 2026 data
Equity Ratio 51.30% 2026 data
Asset Turnover 0.28 2026 data

KANORICHEM Revenue, Net Profit & EBITDA — Year-on-Year Growth

KANORICHEM YoY (Mar 2025 vs Mar 2026) — revenue -28.1%, net profit +180.0%, EBITDA +440.0%, expenses -37.6%. For live price, earnings ratios and company overview, see Kanoria Chemicals & Industries stock price NSE.

Revenue Growth
-28.1%
Year-over-Year
Net Profit Growth
+180.0%
Year-over-Year
EBITDA Growth
+440.0%
Year-over-Year
Expense Growth
-37.6%
Year-over-Year
Assets Growth
-25.4%
Year-over-Year
Equity Growth
+12.4%
Year-over-Year
Operating Cash Flow Growth
-60.5%
Year-over-Year
Investing Cash Flow Growth
-18.0%
Year-over-Year
Financing Cash Flow Growth
+740.0%
Year-over-Year

KANORICHEM Income Statement — Revenue, EBITDA & Net Profit

Kanoria Chemicals & Industries revenue ₹312 Cr, EBITDA ₹34 Cr, net profit ₹32 Cr, EPS ₹7.24 (2026) — net profit margin 10.3%. Analyse Kanoria Chemicals & Industries shareholding analysis to track promoter, FII and institutional holdings.

Periods ₹ Crores
Particulars Mar 2026 Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 Mar 2024 Jun 2024 Dec 2024 Sept 2023 Mar 2023 Jun 2023 Dec 2023 Sept 2022 Mar 2022 Jun 2022 Dec 2022 Sept 2021 Mar 2021 Jun 2021 Dec 2021 Sept 2020 Mar 2020 Jun 2020 Dec 2020 Sept 2019 Mar 2019 Jun 2019 Dec 2019 Sept 2018 Jun 2018 Dec 2018
Revenue 312 316 434 202 268 189 362 386 181 371 445 416 350 362 391 394 389 339 388 337 332 248 264 139 332 254 272 260 248 288 260 265
Expenses 277 204 444 197 246 182 333 382 192 365 422 393 340 356 352 360 369 322 350 310 317 231 248 140 284 250 260 247 231 261 236 256
EBITDA 34 113 -10 6 22 6 29 4 -10 6 23 23 11 6 39 34 20 17 38 26 14 17 16 0 47 4 12 13 17 26 24 9
Operating Profit Margin % 9.00% 3.00% -3.00% 2.00% 7.00% -3.00% 8.00% 0.00% -6.00% 2.00% 5.00% 2.00% 1.00% 2.00% 7.00% 7.00% 4.00% 5.00% 10.00% 5.00% 2.00% 6.00% 7.00% -5.00% 13.00% -1.00% 3.00% 3.00% 2.00% 6.00% 9.00% 3.00%
Depreciation 9 9 17 9 9 8 15 15 8 15 15 15 15 15 14 15 15 14 14 14 14 15 15 14 15 13 12 14 15 13 12 12
Interest 8 9 12 7 8 8 12 11 8 12 11 11 9 8 8 7 10 6 8 5 7 9 10 9 6 9 10 8 10 10 8 8
Profit Before Tax 17 95 -38 -11 6 -9 2 -22 -27 -21 -3 -2 -13 -17 17 12 -5 -4 16 7 -7 -7 -9 -23 26 -18 -10 -9 -7 4 3 -12
Tax -15 3 2 3 2 7 18 1 2 -1 -2 2 2 0 -3 4 -1 5 -5 1 7 0 0 0 0 -10 -1 1 -2 4 2 -1
Net Profit 32 92 -40 -14 4 -17 -16 -23 -29 -21 -1 -4 -15 -17 20 9 -4 -9 21 6 -14 -8 -9 -23 26 -8 -10 -10 -5 0 2 -11
Earnings Per Share (₹) 7.24 21.38 -8.32 -1.79 0.81 -3.18 -2.12 -3.81 -3.81 -4.20 -0.35 -0.60 -1.86 -3.26 4.20 1.89 -0.29 -1.29 4.56 1.13 -2.48 -1.68 -1.83 -4.89 5.33 -1.39 -1.73 -1.82 -0.86 0.44 0.55 -2.68

KANORICHEM Balance Sheet — Assets, Liabilities & Shareholders' Equity

KANORICHEM total assets ₹1,117 Cr, total equity ₹573 Cr, total liabilities ₹ Cr (2026) — ROE 5.6%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 1,117 1,498 1,490 1,481 1,403 1,362 1,374 1,401 1,278 1,210 1,225 982
Current Assets 286 567 563 572 506 459 434 456 395 338 331 292
Fixed Assets 759 865 850 882 863 864 894 850 800 743 512 344
Capital Work in Progress 32 46 47 10 10 14 15 42 12 27 269 182
Investments 106 14 16 17 22 20 26 48 63 100 138 25
Other Assets 0 574 578 573 507 465 439 461 403 340 306 432
LIABILITIES
Total Liabilities
Current Liabilities 235 416 364 366 392 391 389 374 319 330 344 230
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 573 510 618 607 602 595 581 615 594 589 621 510
Share Capital 22 22 22 22 22 22 22 22 22 22 22 22
Reserves & Surplus 551 499 579 584 577 565 547 577 566 558 581 472

KANORICHEM Cash Flow Statement — Operating, Investing & Financing

Kanoria Chemicals & Industries operating cash flow ₹15 Cr, investing ₹-59 Cr, financing ₹42 Cr, net cash flow ₹-3 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities 15 38 26 83 83 31 22 27 30 12 13
Investing Activities -59 -50 -25 -43 -12 -3 -86 -21 7 -109 -156
Financing Activities 42 5 -1 -53 -75 -11 73 -11 -39 82 169
Net Cash Flow -3 -8 0 -13 -4 17 9 -5 -2 -15 27